Treatment Registry
TR-0220 ActiveRecorded September 2026

Compounded semaglutide

Sold by Bioverse · every compounded semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Recorded initial charges

First month

$289

Published monthly rate

$129

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · Starting price · recorded initial monthly payment$289

Added from the figures recorded below.

Price

TermPer monthCharged today
Starting price

“Starting at $289 $129/mo”

Per month$129Charged today$289
Price sources
Visit Bioverse

We earn nothing from this link. It opens Bioverse's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

States10 states: Florida, Texas, New Jersey, Michigan, Ohio, Pennsylvania, Washington, Virginia, North Carolina, and Indiana
PrescriberAsynchronous review
CancellationAt BIOVERSE, you have the flexibility to cancel your subscription if you do so 48 hours before your order is processed. Please note that if the pharmacy has already processed your order, we cannot guarantee refunds for any cancellation requests received after that.

Not yet checked: pharmacy, membership and consult fee.

Recorded from gobioverse.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0220
Medication category
compounded semaglutide
Readings
1

Related records

Other records from Bioverse

All Bioverse programs and terms

Compounded semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 372 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Bioverse — compounded semaglutide (TR-0220). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0220

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.